camellia impressinervis/neoplasms

BACKGROUND OF THE INVENTIVE SUBJECT MATTER 1. Field of the Inventive Subject Matter The present inventive subject matter relates to novel methods for treating prostate cancer, comprising administration of a composition comprising therapeutically effective amounts of supercritical extracts of

BACKGROUND OF THE INVENTIVE SUBJECT MATTER 1. Field of the Inventive Subject Matter The present inventive subject matter relates to novel methods for treating prostatic intraepithelial neoplasia, comprising administration of a composition comprising therapeutically effective amounts of supercritical

BACKGROUND OF THE INVENTIVE SUBJECT MATTER 1. Field of the Inventive Subject Matter The inventive subject matter relates to novel methods for treating oral cancers, comprising administration of a composition comprising therapeutically effective amounts of supercritical extracts of rosemary,

This is a national stage of PCT/IB05/002107 filed Jul. 21, 2005 and published in English. The medicinal properties of Chinese green tea (Camellia sinensis) have been known since antiquity. Based on present-day medical knowledge, tea possesses numerous beneficial properties among which are

1. INTRODUCTION The present invention relates to novel methods and compositions for the treatment of primary and metastatic cancers. These methods and compositions utilize catechins, including but not limited to, epigallocatechin gallate (EGCg), epicatechin (EC), epicatechin gallate (ECG), and

1. INTRODUCTION The present invention relates to novel methods and compositions for the treatment of primary and metastatic cancers. These methods and compositions utilize catechins, including but not limited to, epigallocatechin gallate (EGCg), epicatechin (EC), epicatechin gallate (ECG), and

1. INTRODUCTION The present invention relates to novel methods and sustained release compositions which utilize catechins, including but not limited to, epigallocatechin gallate (EGCg), epicatechin (EC), epicatechin gallate (ECG), and epigallocatechin (EGC), which are found in varying levels in tea

STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT Not Applicable REFERENCE TO SEQUENCE LISTING, A TABLE, OR A COMPUTER PROGRAM LISTING COMPACT DISK APPENDIX Not Applicable BACKGROUND OF THE INVENTION The present invention relates to novel methods and compositions which utilize

The present invention relates to a composition useful for the prevention or reduction of the progression of prostate cancer. In particular, the present invention relates to a composition, which comprises as active ingredients green tea and pomegranate extract, useful for the prevention or reduction

CROSS-REFERENCE TO RELATED APPLICATIONS This application is 371of PCT/EP2009/059531 filed on Jul. 24, 2009, which claims the benefit of European Patent Application No. 08161516.3 filed on Jul. 31, 2008, the contents of each of which are incorporated herein by reference. The present invention relates

FIELD OF INVENTION This invention relates to the field of treating obesity, associated metabolic and physical aberrations such as altered plasma lipid profile and elevated blood pressure. BACKGROUND Obesity is rapidly becoming a major health problem in modern society. It is increasing in prevalence

BACKGROUND OF INVENTION The proteasome is a massive multi-catalytic protease complex that is responsible for degrading the majority of cellular proteins. The 20S-core particle of the 26S proteasome is barrel-shaped, and the sites of proteolytic activity reside on the interior. The eukaryotic

BACKGROUND OF INVENTION The proteasome is a massive multi-catalytic protease complex that is responsible for degrading the majority of cellular proteins. The 20S-core particle of the 26S proteasome is barrel-shaped, and the sites of proteolytic activity reside on the interior. The eukaryotic

BACKGROUND OF INVENTION The proteasome is a massive multi-catalytic protease complex that is responsible for degrading the majority of cellular proteins. The 20S-core particle of the 26S proteasome is barrel-shaped, and the sites of proteolytic activity reside on the interior. The eukaryotic

BACKGROUND OF INVENTION The proteasome is a massive multi-catalytic protease complex that is responsible for degrading the majority of cellular proteins. The 20S-core particle of the 26S proteasome is barrel-shaped, and the sites of proteolytic activity reside on the interior. The eukaryotic